Your browser doesn't support javascript.
loading
Whole Exome Sequencing Reveals the Major Genetic Contributors to Nonsyndromic Tetralogy of Fallot.
Page, Donna J; Miossec, Matthieu J; Williams, Simon G; Monaghan, Richard M; Fotiou, Elisavet; Cordell, Heather J; Sutcliffe, Louise; Topf, Ana; Bourgey, Mathieu; Bourque, Guillaume; Eveleigh, Robert; Dunwoodie, Sally L; Winlaw, David S; Bhattacharya, Shoumo; Breckpot, Jeroen; Devriendt, Koenraad; Gewillig, Marc; Brook, J David; Setchfield, Kerry J; Bu'Lock, Frances A; O'Sullivan, John; Stuart, Graham; Bezzina, Connie R; Mulder, Barbara J M; Postma, Alex V; Bentham, James R; Baron, Martin; Bhaskar, Sanjeev S; Black, Graeme C; Newman, William G; Hentges, Kathryn E; Lathrop, G Mark; Santibanez-Koref, Mauro; Keavney, Bernard D.
Afiliação
  • Page DJ; From the Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine, and Health, Manchester Academic Health Science Centre, University of Manchester, United Kingdom (D.J.P., S.G.W., R.M.M., E.F., B.D.K.).
  • Miossec MJ; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom (M.J.M., H.J.C., L.S., A.T., M.S.-K.).
  • Williams SG; Center for Bioinformatics and Integrative Biology, Faculty of Biological Sciences, Universidad Andrés Bello, Santiago, Chile (M.J.M.).
  • Monaghan RM; From the Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine, and Health, Manchester Academic Health Science Centre, University of Manchester, United Kingdom (D.J.P., S.G.W., R.M.M., E.F., B.D.K.).
  • Fotiou E; From the Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine, and Health, Manchester Academic Health Science Centre, University of Manchester, United Kingdom (D.J.P., S.G.W., R.M.M., E.F., B.D.K.).
  • Cordell HJ; From the Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine, and Health, Manchester Academic Health Science Centre, University of Manchester, United Kingdom (D.J.P., S.G.W., R.M.M., E.F., B.D.K.).
  • Sutcliffe L; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom (M.J.M., H.J.C., L.S., A.T., M.S.-K.).
  • Bourgey M; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom (M.J.M., H.J.C., L.S., A.T., M.S.-K.).
  • Bourque G; Canadian Centre for Computational Genomics, Montréal, QC, Canada (M.B.).
  • Eveleigh R; McGill Genome Center, Montréal, QC, Canada (M.B., G.B., R.E., G.M.L.).
  • Dunwoodie SL; McGill Genome Center, Montréal, QC, Canada (M.B., G.B., R.E., G.M.L.).
  • Winlaw DS; McGill Genome Center, Montréal, QC, Canada (M.B., G.B., R.E., G.M.L.).
  • Bhattacharya S; Chain Reaction Program in Congenital Heart Disease Research, Victor Chang Cardiac Research Institute, Sydney, NSW, Australia (S.L.D.).
  • Breckpot J; Faculties of Medicine and Science, University of New South Wales, Sydney (S.L.D.).
  • Devriendt K; Heart Centre for Children, The Children's Hospital at Westmead, Sydney, NSW (S.L.D.).
  • Gewillig M; School of Child and Adolescent Health, Sydney Medical School, University of Sydney (D.S.W.).
  • Brook JD; Victor Chang Cardiac Research Institute, NSW, Australia (D.S.W.).
  • Setchfield KJ; RDM Cardiovascular Medicine, Wellcome Centre for Human Genetics, University of Oxford (D.S.W., S.B.).
  • Bu'Lock FA; RDM Cardiovascular Medicine, Wellcome Centre for Human Genetics, University of Oxford (D.S.W., S.B.).
  • O'Sullivan J; Center for Human Genetics, Catholic University Leuven, Belgium (S.B., J.B., K.D.).
  • Stuart G; Center for Human Genetics, Catholic University Leuven, Belgium (S.B., J.B., K.D.).
  • Bezzina CR; Pediatric and Congenital Cardiology, UZ Leuven (J.B., M.G.).
  • Mulder BJM; Center for Human Genetics, Catholic University Leuven, Belgium (S.B., J.B., K.D.).
  • Postma AV; Pediatric and Congenital Cardiology, UZ Leuven (J.B., M.G.).
  • Bentham JR; School of Life Sciences, University of Nottingham, Queen's Medical Centre (J.D.B., K.J.S.).
  • Baron M; School of Life Sciences, University of Nottingham, Queen's Medical Centre (J.D.B., K.J.S.).
  • Bhaskar SS; Congenital and Paediatric Cardiology, East Midlands Congenital Heart Centre and University of Leicester, Glenfield Hospital (F.A.B.).
  • Black GC; Adult Congenital and Paediatric Cardiac Unit, Freeman Hospital, Newcastle upon Tyne (J.O.).
  • Newman WG; University Hospitals Bristol NHS Foundation Trust, Bristol (G.S.).
  • Hentges KE; Heart Center, Department of Clinical and Experimental Cardiology (C.R.B.), Academic Medical Center, Amsterdam, the Netherlands.
  • Lathrop GM; Department of Medical Biology (B.J.M.M.), Academic Medical Center, Amsterdam, the Netherlands.
  • Santibanez-Koref M; Department of Clinical Genetics (A.V.P.), Academic Medical Center, Amsterdam, the Netherlands.
  • Keavney BD; Department of Paediatric Cardiology, Yorkshire Heart Centre, Leeds (J.R.B.).
Circ Res ; 124(4): 553-563, 2019 02 15.
Article em En | MEDLINE | ID: mdl-30582441
RATIONALE: Familial recurrence studies provide strong evidence for a genetic component to the predisposition to sporadic, nonsyndromic Tetralogy of Fallot (TOF), the most common cyanotic congenital heart disease phenotype. Rare genetic variants have been identified as important contributors to the risk of congenital heart disease, but relatively small numbers of TOF cases have been studied to date. OBJECTIVE: We used whole exome sequencing to assess the prevalence of unique, deleterious variants in the largest cohort of nonsyndromic TOF patients reported to date. METHODS AND RESULTS: Eight hundred twenty-nine TOF patients underwent whole exome sequencing. The presence of unique, deleterious variants was determined; defined by their absence in the Genome Aggregation Database and a scaled combined annotation-dependent depletion score of ≥20. The clustering of variants in 2 genes, NOTCH1 and FLT4, surpassed thresholds for genome-wide significance (assigned as P<5×10-8) after correction for multiple comparisons. NOTCH1 was most frequently found to harbor unique, deleterious variants. Thirty-one changes were observed in 37 probands (4.5%; 95% CI, 3.2%-6.1%) and included 7 loss-of-function variants 22 missense variants and 2 in-frame indels. Sanger sequencing of the unaffected parents of 7 cases identified 5 de novo variants. Three NOTCH1 variants (p.G200R, p.C607Y, and p.N1875S) were subjected to functional evaluation, and 2 showed a reduction in Jagged1-induced NOTCH signaling. FLT4 variants were found in 2.4% (95% CI, 1.6%-3.8%) of TOF patients, with 21 patients harboring 22 unique, deleterious variants. The variants identified were distinct to those that cause the congenital lymphoedema syndrome Milroy disease. In addition to NOTCH1, FLT4 and the well-established TOF gene, TBX1, we identified potential association with variants in several other candidates, including RYR1, ZFPM1, CAMTA2, DLX6, and PCM1. CONCLUSIONS: The NOTCH1 locus is the most frequent site of genetic variants predisposing to nonsyndromic TOF, followed by FLT4. Together, variants in these genes are found in almost 7% of TOF patients.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tetralogia de Fallot / Taxa de Mutação / Exoma Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tetralogia de Fallot / Taxa de Mutação / Exoma Idioma: En Ano de publicação: 2019 Tipo de documento: Article